Glycated albumin activates NADPH oxidase in rat mesangial cells through up-regulation of p47phox

Biochemical and Biophysical Research Communications

Volumn 397, Issue 1, 2010, Pages 5-11

  Li, Yanzhang ^a   Wang, Shuxia ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Extracellular matrix protein; Glycated albumin; Mesangial cells; NADPH oxidase; p47phox; TGF

Indexed keywords

FIBRONECTIN; GLYCOSYLATED ALBUMIN; OXIDOREDUCTASE; PROTEIN P47PHOX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA; SUPEROXIDE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION;

ANIMALS; CELLS, CULTURED; DIABETIC NEPHROPATHIES; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; FIBRONECTINS; FREE RADICAL SCAVENGERS; MESANGIAL CELLS; NADPH OXIDASE; RATS; SERUM ALBUMIN; SUPEROXIDES; TRANSFORMING GROWTH FACTOR ALPHA; UP-REGULATION;

RATTUS;

EID: 77953610731     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.04.084     Document Type: Article

References (34)

1. Lapolla A., Fedele D., Reitano R., Arico N.C., Seraglia R., Traldi P., Marotta E., and Tonani R. Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides. J. Am. Soc. Mass Spectrom. 15 (2004) 496-509
2. Cohen M.P., and Ziyadeh F.N. Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy. J. Am. Soc. Nephrol. 7 (1996) 183-190
3. Guthrow C.E., Morris M.A., Day J.F., Thorpe S.R., and Baynes J.W. Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc. Natl. Acad. Sci. USA 76 (1979) 4258-4261
4. Fukami K., Yamagishi S., Ueda S., and Okuda S. Role of AGEs in diabetic nephropathy. Curr. Pharm. Des. 14 (2008) 946-952
5. Tanji N., Markowitz G.S., Fu C., Kislinger T., Taguchi A., Pischetsrieder M., Stern D., Schmidt A.M., and D'Agati V.D. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J. Am. Soc. Nephrol. 11 (2000) 1656-1666
6. Cohen M.P., Ziyadeh F.N., Lautenslager G.T., Cohen J.A., and Shearman C.W. Glycated albumin stimulation of PKC-beta activity is linked to increased collagen IV in mesangial cells. Am. J. Physiol. 276 (1999) F684-F690
7. Ziyadeh F.N., Han D.C., Cohen J.A., Guo J., and Cohen M.P. Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system. Kidney Int. 53 (1998) 631-638
8. Fukami K., Ueda S., Yamagishi S., Kato S., Inagaki Y., Takeuchi M., Motomiya Y., Bucala R., Iida S., Tamaki K., Imaizumi T., Cooper M.E., and Okuda S. AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction. Kidney Int. 66 (2004) 2137-2147
9. Lal M.A., Brismar H., Eklof A.C., and Aperia A. Role of oxidative stress in advanced glycation end product-induced mesangial cell activation. Kidney Int. 61 (2002) 2006-2014
10. Yoo C.W., Song C.Y., Kim B.C., Hong H.K., and Lee H.S. Glycated albumin induces superoxide generation in mesangial cells. Cell. Physiol. Biochem. 14 (2004) 361-368
11. Li J.M., and Shah A.M. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J. Am. Soc. Nephrol. 14 (2003) S221-S226
12. Babior B.M. NADPH oxidase: an update. Blood 93 (1999) 1464-1476
13. Gill P.S., and Wilcox C.S. NADPH oxidases in the kidney. Antioxid. Redox Signal. 8 (2006) 1597-1607
14. Miyata K., Rahman M., Shokoji T., Nagai Y., Zhang G.X., Sun G.P., Kimura S., Yukimura T., Kiyomoto H., Kohno M., Abe Y., and Nishiyama A. Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells. J. Am. Soc. Nephrol. 16 (2005) 2906-2912
15. Onozato M.L., Tojo A., Goto A., Fujita T., and Wilcox C.S. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int. 61 (2002) 186-194
16. Matsunaga-Irie S., Maruyama T., Yamamoto Y., Motohashi Y., Hirose H., Shimada A., Murata M., and Saruta T. Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients. Diabetes Care 27 (2004) 303-307
17. Thallas-Bonke V., Thorpe S.R., Coughlan M.T., Fukami K., Yap F.Y., Sourris K.C., Penfold S.A., Bach L.A., Cooper M.E., and Forbes J.M. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes 57 (2008) 460-469
18. Nevado J., Peiro C., Vallejo S., El-Assar M., Lafuente N., Matesanz N., Azcutia V., Cercas E., Sanchez-Ferrer C.F., and Rodriguez-Manas L. Amadori adducts activate nuclear factor-kappaB-related proinflammatory genes in cultured human peritoneal mesothelial cells. Br. J. Pharmacol. 146 (2005) 268-279
19. Wang S., Shiva S., Poczatek M.H., Darley-Usmar V., and Murphy-Ullrich J.E. Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-beta activation in mesangial cells. J. Biol. Chem. 277 (2002) 9880-9888
20. Griendling K.K., Minieri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74 (1994) 1141-1148
21. Chabrashvili T., Kitiyakara C., Blau J., Karber A., Aslam S., Welch W.J., and Wilcox C.S. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 (2003) R117-R124
22. Heumuller S., Wind S., Barbosa-Sicard E., Schmidt H.H., Busse R., Schroder K., and Brandes R.P. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51 (2008) 211-217
23. Chen S., Cohen M.P., and Ziyadeh F.N. Amadori-glycated albumin in diabetic nephropathy: pathophysiologic connections. Kidney Int. Suppl. 77 (2000) S40-S44
24. Cohen M.P., Hud E., and Wu V.Y. Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin. Kidney Int. 45 (1994) 1673-1679
25. Cohen M.P., Hud E., Wu V.Y., and Ziyadeh F.N. Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcription. Mol. Cell. Biochem. 151 (1995) 61-67
26. Cohen M.P., Lautenslager G.T., Hud E., Shea E., Wang A., Chen S., and Shearman C.W. Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency. Am. J. Physiol. Renal. Physiol. 292 (2007) F789-F795
27. Zhang M., Kho A.L., Anilkumar N., Chibber R., Pagano P.J., Shah A.M., and Cave A.C. Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase. Circulation 113 (2006) 1235-1243
28. Hattori Y., Banba N., Gross S.S., and Kasai K. Glycated serum albumin-induced nitric oxide production in vascular smooth muscle cells by nuclear factor kappaB-dependent transcriptional activation of inducible nitric oxide synthase. Biochem. Biophys. Res. Commun. 259 (1999) 128-132
29. Salazar R., Brandt R., and Krantz S. Binding of Amadori glucose-modified albumin by the monocytic cell line MonoMac 6 activates protein kinase C epsilon protein tyrosine kinases and the transcription factors AP-1 and NF-kappaB. Glycoconj. J. 18 (2001) 769-777
30. De Oliveira C., Colette C., Monnier L., Descomps B., and Pares-Herbute N. Insulin alters nuclear factor-lambdaB and peroxisome proliferator-activated receptor-gamma protein expression induced by glycated bovine serum albumin in vascular smooth-muscle cells. J. Lab. Clin. Med. 145 (2005) 144-150
31. Higai K., Shimamura A., and Matsumoto K. Amadori-modified glycated albumin predominantly induces E-selectin expression on human umbilical vein endothelial cells through NADPH oxidase activation. Clin. Chim. Acta 367 (2006) 137-143
32. Brandt R., and Krantz S. Glycated albumin (Amadori product) induces activation of MAP kinases in monocyte-like MonoMac 6 cells. Biochim. Biophys. Acta 1760 (2006) 1749-1753
33. Cohen M.P., Shea E., Chen S., and Shearman C.W. Glycated albumin increases oxidative stress, activates NF-kappa B and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-beta 1 production in macrophage RAW cells. J. Lab. Clin. Med. 141 (2003) 242-249
34. Guijarro C., and Egido J. Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int. 59 (2001) 415-424